Literature DB >> 7062252

Glucosylated albumin and its influence on salicylate binding.

K A Mereish, H Rosenberg, J Cobby.   

Abstract

Human serum albumin was incubated at 37 degrees in 0.01 M phosphate buffer (pH 7.4) under sterile conditions for up to 10 days with labeled [14C]glucose (1-25 mg/ml). Glucose incorporated into albumin was calculated following extensive dialysis of the incubation mixture. The results indicated that glucose reacted with albumin by a nonenzymatic process involving Schiff base formation and Amadori rearrangement to a stable ketoamine derivative. The degree of glucosylation was dependent on the reaction time, glucose concentration, and pH. Glucosylation was enhanced when albumin was fatty acid free. Glucosylated albumin was separated from unmodified albumin by cation exchange chromatography on carboxymethylcellulose and quantitated colorimetrically with 2-thiobarbituric acid. Salicylate binding studies revealed that the glucosylated component had a decreased salicylate binding capacity accompanied by a reduction in the number of classes of binding sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062252     DOI: 10.1002/jps.2600710223

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

1.  L-Arginine inhibits in vitro nonenzymatic glycation and advanced glycosylated end product formation of human serum albumin.

Authors:  D A Servetnick; D Bryant; K J Wells-Knecht; P L Wiesenfeld
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 2.  Non-enzymatic glycosylation and the chronic complications of diabetes: an overview.

Authors:  L Kennedy; J W Baynes
Journal:  Diabetologia       Date:  1984-02       Impact factor: 10.122

Review 3.  The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans.

Authors:  P R Gwilt; R R Nahhas; W G Tracewell
Journal:  Clin Pharmacokinet       Date:  1991-06       Impact factor: 6.447

4.  Plasma protein binding of lidocaine and warfarin in insulin-dependent and non-insulin-dependent diabetes mellitus.

Authors:  S O'Byrne; M G Barry; W C Collins; P O'Connor; M J Cullen; J Feely
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

Review 5.  Review: Glycation of human serum albumin.

Authors:  Jeanethe Anguizola; Ryan Matsuda; Omar S Barnaby; K S Hoy; Chunling Wa; Erin DeBolt; Michelle Koke; David S Hage
Journal:  Clin Chim Acta       Date:  2013-07-24       Impact factor: 3.786

6.  Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Chunling Wa; Ronald L Cerny; William A Clarke; David S Hage
Journal:  Clin Chim Acta       Date:  2007-06-23       Impact factor: 3.786

7.  The protein binding of phenytoin, propranolol, diazepam, and AL01576 (an aldose reductase inhibitor) in human and rat diabetic serum.

Authors:  P J McNamara; R A Blouin; R K Brazzell
Journal:  Pharm Res       Date:  1988-05       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.